Drug Research

The United Kingdom has once again become a part of Horizon Europe through a fresh agreement with the European Union. This development opens up opportunities for British scientists to engage in the world's largest research and development collaboration program....

The UK government dedicates £5.5 million towards establishing a Medicines Manufacturing Skills Centre of Excellence. This center aims to bolster the pool of skilled individuals in the UK's life sciences sector, fostering innovation and enabling the country to respond...

Global contract development and manufacturing organisation (CDMO) Recipharm is partnering with Ahead Therapeutics to develop a ground-breaking treatment for a rare autoimmune disease, myasthenia gravis. Ahead Therapeutics is a Spanish start-up biotech company, using proprietary technology to develop treatments for different autoimmune disorders. Under...

In 2023, the pharmaceutical industry, particularly antibiotic manufacturers, has experienced a range of changes that span from supply chain challenges to new regulatory opportunities. A recent insight from the Access to Medicine Foundation has brought attention to the issue...

The API CDMO market underwent significant changes due to the COVID-19 pandemic. The global rollout of vaccines and therapeutics against the virus led to an unprecedented surge in demand for CDMO (Contract Development and Manufacturing Organization) services. CDMOs played...

The summer of 2023 might become the hottest on record, raising concerns about climate change and the need to prepare for more instances of extreme heat. The occurrence of El Niño, a global weather phenomenon, coupled with high temperatures...

Pharmaceutical companies have collaborated with the WHO through the Sustainable Markets Initiative to implement new supplier requirements, aiming to hasten the healthcare sector's shift to net-zero emissions. The CEOs of AstraZeneca, GSK, Novo Nordisk, Merck, Roche, Sanofi, and Samsung...